nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine
|
Kaashoek, M.J. |
|
1994 |
12 |
5 |
p. 439-444 6 p. |
artikel |
2 |
Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins
|
Vakharia, V.N. |
|
1994 |
12 |
5 |
p. 452-456 5 p. |
artikel |
3 |
Adverse reactions after diphtheria—tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination
|
Blennow, Margareta |
|
1994 |
12 |
5 |
p. 427-430 4 p. |
artikel |
4 |
Announcement
|
|
|
1994 |
12 |
5 |
p. 479- 1 p. |
artikel |
5 |
Antigenic competition in a multivalent foot rot vaccine
|
Hunt, Jacqueline D. |
|
1994 |
12 |
5 |
p. 457-464 8 p. |
artikel |
6 |
Calendar
|
|
|
1994 |
12 |
5 |
p. 480- 1 p. |
artikel |
7 |
Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants
|
Al-Shakhshir, Ragheb |
|
1994 |
12 |
5 |
p. 472-474 3 p. |
artikel |
8 |
Haemolytic activity of calcium phosphate adjuvant
|
Léry, Louis |
|
1994 |
12 |
5 |
p. 475- 1 p. |
artikel |
9 |
Haemophilus type B conjugate vaccine: postimmunization kinetics of IgM and IgG antibody responses in ten vaccinated children
|
Vincent-Ballereau, Françoise |
|
1994 |
12 |
5 |
p. 403-405 3 p. |
artikel |
10 |
HIV immunotherapy
|
Slade, Herbert B. |
|
1994 |
12 |
5 |
p. 476- 1 p. |
artikel |
11 |
Identification of Brucella abortus B19 vaccine strain by the detection of DNA polymorphism at the ery locus
|
Sangari, Félix J. |
|
1994 |
12 |
5 |
p. 435-438 4 p. |
artikel |
12 |
Immunogenicity of a mycobacterial T-cell epitope expressed in outer membrane protein PhoE of Escherichia coli
|
Janssen, Riny |
|
1994 |
12 |
5 |
p. 406-409 4 p. |
artikel |
13 |
Immunogenicity of an inactivated hepatitis A vaccine after exposure at 37°C for 1 week
|
Wiedermann, G. |
|
1994 |
12 |
5 |
p. 401-402 2 p. |
artikel |
14 |
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens
|
Conley, Anthony J. |
|
1994 |
12 |
5 |
p. 445-451 7 p. |
artikel |
15 |
In vitro production of antigen-activated dendritic cell precursor for use as an immunogen in a vaccine; application in juvenile diabetes, multiple sclerosis, myasthenia gravis and atopic dermatitis therapy
|
|
|
1994 |
12 |
5 |
p. 478- 1 p. |
artikel |
16 |
Methods for regulating T-lymphocyte mediated response; CD28 pathway immunoregulation; recombinant stimulatory ligand, monoclonal antibody
|
|
|
1994 |
12 |
5 |
p. 478- 1 p. |
artikel |
17 |
Multiple sclerosis-associated virus cell culture and cell line containing interferon-beta antibody virus-inhibitor; monoclonal antibody; application as a vaccine and in disease diagnosis
|
|
|
1994 |
12 |
5 |
p. 478- 1 p. |
artikel |
18 |
New non-infectious but immunogenic HIV virus particle; with mutation in region vital for RNA packaging, useful in recombinant vaccine and diagnostic reagent production
|
|
|
1994 |
12 |
5 |
p. 478- 1 p. |
artikel |
19 |
New strategies for using mucosal vaccination to achieve more effective immunization
|
Walker, Richard I. |
|
1994 |
12 |
5 |
p. 387-400 14 p. |
artikel |
20 |
Persistence of vaccine-induced antibodies for hepatitis A virus
|
Totos, Gregory |
|
1994 |
12 |
5 |
p. 475- 1 p. |
artikel |
21 |
Pseudomonas aeruginosa in human diseases
|
Govan, J.R.W. |
|
1994 |
12 |
5 |
p. 477- 1 p. |
artikel |
22 |
Randomized comparative trial of interferon-α versus placebo in hepatitis B vaccine non-responders and hyporesponders
|
Goldwater, Paul N. |
|
1994 |
12 |
5 |
p. 410-414 5 p. |
artikel |
23 |
Recombinant vaccinia virus expression of Anaplasma marginale surface protein MSP-1a: effect of promoters, leader sequences and GPI anchor sequence on antibody response
|
McGuire, Travis C. |
|
1994 |
12 |
5 |
p. 465-471 7 p. |
artikel |
24 |
Role of EIPV in 1988 Israel polio outbreak
|
Slater, Paul E. |
|
1994 |
12 |
5 |
p. 476- 1 p. |
artikel |
25 |
Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine
|
Tamura, Shin-ichi |
|
1994 |
12 |
5 |
p. 419-426 8 p. |
artikel |
26 |
Termination of pregnancy in mice following administration of antibodies to the pentadecapeptide 10–24 of chicken riboflavin carrier protein: identification of a bioneutralizing epitope of chicken riboflavin carrier protein
|
Natraj, U. |
|
1994 |
12 |
5 |
p. 431-434 4 p. |
artikel |
27 |
Tumour cell soluble immunosuppressive reduces the T-lymphocyte antigen receptor subunit protein; antibody and new antisense construct; application in cancer therapy and as a vaccine
|
|
|
1994 |
12 |
5 |
p. 478- 1 p. |
artikel |
28 |
Vaccination in food animal populations
|
van Oirschot, J.T. |
|
1994 |
12 |
5 |
p. 415-418 4 p. |
artikel |
29 |
Vaccines 93: Modern approaches to new vaccines including prevention of AIDS
|
Spier, R.E. |
|
1994 |
12 |
5 |
p. 476-477 2 p. |
artikel |